MTOR and nonpapillary renal cell carcinoma: Thus, the common hyperactivation of the mTORC1 signalling pathway in ccRCC could, at least in part, be a consequence of the high expression of KLF6 and the downstream transcription of the mTOR agonist PDGFB.